Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Sunovion Pharmaceuticals Inc patents


Recent patent applications related to Sunovion Pharmaceuticals Inc. Sunovion Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Sunovion Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Sunovion Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sunovion Pharmaceuticals Inc-related inventors


Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Methods and pharmaceutical unit dosage forms for treating parkinson's disease in a subject (e.g., an “off” episode in a subject having parkinson's disease) are described. The pharmaceutical unit dosage forms are films having a first portion including particles containing an acid addition salt of apomorphine and a second portion containing a ph neutralizing agent. ... Sunovion Pharmaceuticals Inc

Heteroaryl compounds and methods of use thereof

Provided herein are thiophene compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.. ... Sunovion Pharmaceuticals Inc

Heteroaryl compounds and methods of use thereof

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as cns disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.. ... Sunovion Pharmaceuticals Inc

Formulations, salts and polymorphs of transnorsertraline and uses thereof

Provided herein are pharmaceutical compositions comprising transnorsertraline, salts and polymorphic forms of transnorsertraline, methods of making the compositions, and methods for their use for the treatment of cns diseases, including depression.. . ... Sunovion Pharmaceuticals Inc

Substituted quinolines as pde-10 inhibitors

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as cns disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.. ... Sunovion Pharmaceuticals Inc

Metabotrophic glutamate receptor 5 modulators and methods use thereof

Compounds that modulate glur5 activity and methods of using the same are disclosed.. . ... Sunovion Pharmaceuticals Inc

Sunovion Pharmaceuticals Inc.

. . ... Sunovion Pharmaceuticals Inc

Sunovion Pharmaceuticals Inc.

. . ... Sunovion Pharmaceuticals Inc

Preparation of chiral amides and amines

This invention provides a convenient method for converting oximes into enamides. The process does not require the use of metallic reagents. ... Sunovion Pharmaceuticals Inc

Dosage of dasotraline and method for treatment of adhd

Dosage forms and treatment regimens employing dasotraline for treating attention deficit hyperactivity disorder (adhd) are disclosed. The compositions described herein exhibit no abuse potential.. ... Sunovion Pharmaceuticals Inc

Methods and compositions of dasotraline for treatment of adhd

Dosage forms and treatment regimens employing dasotraline for treating attention deficit hyperactivity disorder (adhd) are disclosed. The compositions described herein exhibit no abuse potential.. ... Sunovion Pharmaceuticals Inc

Phenyl substituted cycloalkylamines as monoamine reputake inhibitors

Phenyl-substituted cyclohexylamine derivatives and methods for their synthesis and characterization are disclosed. Use of these compounds to treat/prevent neurological disorders as well as methods for their synthesis are set forth herein. ... Sunovion Pharmaceuticals Inc

Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine

Treatment of cns disorders with (1r,4s)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1s,4r)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is also disclosed. ... Sunovion Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sunovion Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sunovion Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###